"10.1371_journal.pone.0012873","plos one","2010-09-21T00:00:00Z","Walter Jaoko; Etienne Karita; Kayitesi Kayitenkore; Gloria Omosa-Manyonyi; Susan Allen; Soe Than; Elizabeth M Adams; Barney S Graham; Richard A Koup; Robert T Bailer; Carol Smith; Len Dally; Bashir Farah; Omu Anzala; Claude M Muvunyi; Jean Bizimana; Tony Tarragona-Fiol; Philip J Bergin; Peter Hayes; Martin Ho; Kelley Loughran; Wendy Komaroff; Gwynneth Stevens; Helen Thomson; Mark J Boaz; Josephine H Cox; Claudia Schmidt; Jill Gilmour; Gary J Nabel; Patricia Fast; Job Bwayo","Kenya AIDS Vaccine Initiative (KAVI), Nairobi, Kenya; Projet San Francisco (PSF), Rwanda-Zambia HIV Research Project, Kigali, Rwanda; Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America; Vaccine Clinical Research Branch (VCRB), Vaccine Research Program (VRP)/Division of AIDS (DAIDS)/National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH), Bethesda, Maryland, United States of America; Vaccine Research Center (VRC)/NIAID/NIH, Bethesda, Maryland, United States of America; The EMMES Corporation, Rockville, Maryland, United States of America; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom","Conceived and designed the experiments: ST BSG JG GJN PF. Performed the experiments: WJ EK KK GSOM BF OA CMM JB TTF PJB PH GS JC. Analyzed the data: BSG RAK RTB CS LD MH MB JC JG PF. Contributed reagents/materials/analysis tools: RAK RTB JG GJN. Wrote the paper: BSG CS LD MB JC CS PF. Director of the Rwanda Zambia HIV Research Group: SAA. Medical monitoring: EA. Data manager: KL. Project Manager: WK. Director of African Laboratory Operations: GS. African Clinical Program Manager: HT. Principal Investigator at KAVI: JJB.","IAVI is a non-profit organization. None of the co-authors affiliated with IAVI reports any competing interest, that might interfere with the objective assessment of this manuscript or with the ability to adhere to all PloS ONE policies on sharing data and materials. Gary J. Nabel is named on patent applications for the DNA and adenovirus vector components of this vaccine concept (patents # E-173-2004/0-US-01, E-355-2003/0-US-01, and E-267-2004/0). This does not alter the authors ability to adhere to all PloS ONE policies on sharing data and materials. None of the co-authors employed by government agencies declares any competing interest that might interfere with the objective assessment of this manuscript or with the ability to adhere to all PloS ONE policies on sharing data and materials. Affiliations of Carol Smith, Len Dally, Martin Ho, Kelley Loughran, Mark Boaz and Soe Than do not alter the authors ability to adhere to all the PLoS ONE policies on sharing data and materials. Drs. Than and Boaz report no competing interests.","2010","09","Walter Jaoko","WJ",31,FALSE,5,13,10,6,TRUE,FALSE,FALSE,0,NA,FALSE
